News in Brief
Elekta gets FDA clearance for Monaco 5
November 27, 2013 -- Radiation oncology firm Elekta has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Monaco 5 radiation therapy treatment planning systems.
CMC lands Orphan Drug Designation by FDA
November 27, 2013 -- Swedish contrast media developer CMC Contrast has received an Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for its CMC-001 liver-specific contrast agent.
RCR praises new report on variation in diagnostic tests
November 27, 2013 -- The U.K. Royal College of Radiologists (RCR) said that it welcomes the release of a National Health Service (NHS) report revealing geographic variations in the range of diagnostic patient tests -- including imaging studies -- that are being requested across the U.K.